{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:33:46Z","timestamp":1790004826633,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31770957"],"award-info":[{"award-number":["31770957"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91842102"],"award-info":[{"award-number":["91842102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170896"],"award-info":[{"award-number":["32170896"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Beijing"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-022-00595-9","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T16:03:30Z","timestamp":1656950610000},"page":"867-882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["PD-1 signaling facilitates activation of lymphoid tissue inducer cells by restraining fatty acid oxidation"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0317-2337","authenticated-orcid":false,"given":"Di","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luni","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengwei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yime","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanqun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinlian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1744-6378","authenticated-orcid":false,"given":"Chao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"key":"595_CR1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","volume":"8","author":"SC Wei","year":"2018","unstructured":"Wei, S. C., Duffy, C. R. & Allison, J. P. Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov. 8, 1069\u20131086 (2018).","journal-title":"Cancer Discov."},{"key":"595_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir, M. E., Butte, M. J., Freeman, G. J. & Sharpe, A. H. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26, 677\u2013704 (2008).","journal-title":"Annu. Rev. Immunol."},{"key":"595_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252\u2013264 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"595_CR4","doi-asserted-by":"publisher","first-page":"iv119","DOI":"10.1093\/annonc\/mdx225","volume":"28","author":"J Haanen","year":"2017","unstructured":"Haanen, J. et al. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 28, iv119\u2013iv142 (2017).","journal-title":"Ann. Oncol."},{"key":"595_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow, M. A., Sidlow, R. & Hellmann, M. D. Immune-related adverse events associated with immune checkpoint blockade. N. Engl. J. Med. 378, 158\u2013168 (2018).","journal-title":"N. Engl. J. Med."},{"key":"595_CR6","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1126\/science.1106442","volume":"307","author":"TT Macdonald","year":"2005","unstructured":"Macdonald, T. T. & Monteleone, G. Immunity, inflammation, and allergy in the gut. Science 307, 1920\u20131925 (2005).","journal-title":"Science"},{"key":"595_CR7","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell 174, 1054\u20131066 (2018).","journal-title":"Cell"},{"key":"595_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits, H. et al. Innate lymphoid cells\u2014a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145\u2013149 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"595_CR9","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","volume":"38","author":"A Fuchs","year":"2013","unstructured":"Fuchs, A. et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-\u03b3-producing cells. Immunity 38, 769\u2013781 (2013).","journal-title":"Immunity"},{"key":"595_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","volume":"157","author":"CSN Klose","year":"2014","unstructured":"Klose, C. S. N. et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157, 340\u2013356 (2014).","journal-title":"Cell"},{"key":"595_CR11","doi-asserted-by":"publisher","first-page":"191-8.e1-4","DOI":"10.1016\/j.jaci.2011.09.041","volume":"129","author":"JL Barlow","year":"2012","unstructured":"Barlow, J. L. et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J. Allergy Clin. Immunol. 129, 191-8.e1-4 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"595_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature12526","volume":"502","author":"JC Nussbaum","year":"2013","unstructured":"Nussbaum, J. C. et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502, 245\u2013248 (2013).","journal-title":"Nature"},{"key":"595_CR13","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1182\/blood-2010-09-303081","volume":"117","author":"Q Tang","year":"2011","unstructured":"Tang, Q. et al. Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue. Blood 117, 4052\u20134055 (2011).","journal-title":"Blood"},{"key":"595_CR14","doi-asserted-by":"publisher","first-page":"1249288","DOI":"10.1126\/science.1249288","volume":"343","author":"A Mortha","year":"2014","unstructured":"Mortha, A. et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 343, 1249288 (2014).","journal-title":"Science"},{"key":"595_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm.3423","volume":"20","author":"HY Kim","year":"2014","unstructured":"Kim, H. Y. et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat. Med. 20, 54\u201361 (2014).","journal-title":"Nat. Med."},{"key":"595_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nature11813","volume":"494","author":"CSN Klose","year":"2013","unstructured":"Klose, C. S. N. et al. A T-bet gradient controls the fate and function of CCR6\u2212ROR\u03b3t+ innate lymphoid cells. Nature 494, 261\u2013265 (2013).","journal-title":"Nature"},{"key":"595_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cytogfr.2018.02.004","volume":"42","author":"C Zhong","year":"2018","unstructured":"Zhong, C., Zheng, M. & Zhu, J. Lymphoid tissue inducer\u2014a divergent member of the ILC family. Cytokine Growth Factor Rev. 42, 5\u201312 (2018).","journal-title":"Cytokine Growth Factor Rev."},{"key":"595_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nature13047","volume":"508","author":"MG Constantinides","year":"2014","unstructured":"Constantinides, M. G., McDonald, B. D., Verhoef, P. A. & Bendelac, A. A committed precursor to innate lymphoid cells. Nature 508, 397\u2013401 (2014).","journal-title":"Nature"},{"key":"595_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.immuni.2019.12.001","volume":"52","author":"C Zhong","year":"2020","unstructured":"Zhong, C. et al. Differential expression of the transcription factor GATA3 specifies lineage and functions of innate lymphoid cells. Immunity 52, 83\u201395.e4 (2020).","journal-title":"Immunity"},{"key":"595_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s13238-017-0369-7","volume":"8","author":"C Zhong","year":"2017","unstructured":"Zhong, C. & Zhu, J. Transcriptional regulators dictate innate lymphoid cell fates. Protein Cell 8, 242\u2013254 (2017).","journal-title":"Protein Cell"},{"key":"595_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/ni.3332","volume":"17","author":"LC Rankin","year":"2016","unstructured":"Rankin, L. C. et al. Complementarity and redundancy of IL-22-producing innate lymphoid cells. Nat. Immunol. 17, 179\u2013186 (2016).","journal-title":"Nat. Immunol."},{"key":"595_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nm1720","volume":"14","author":"Y Zheng","year":"2008","unstructured":"Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282\u2013289 (2008).","journal-title":"Nat. Med."},{"key":"595_CR23","doi-asserted-by":"publisher","first-page":"1254009","DOI":"10.1126\/science.1254009","volume":"345","author":"Y Goto","year":"2014","unstructured":"Goto, Y. et al. Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 345, 1254009 (2014).","journal-title":"Science"},{"key":"595_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.immuni.2010.12.009","volume":"34","author":"GF Sonnenberg","year":"2011","unstructured":"Sonnenberg, G. F., Monticelli, L. A., Elloso, M. M., Fouser, L. A. & Artis, D. CD4+ lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34, 122\u2013134 (2011).","journal-title":"Immunity"},{"key":"595_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature20105","volume":"539","author":"Y Yu","year":"2016","unstructured":"Yu, Y. et al. Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its development pathway. Nature 539, 102\u2013106 (2016).","journal-title":"Nature"},{"key":"595_CR26","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1084\/jem.20161653","volume":"214","author":"S Taylor","year":"2017","unstructured":"Taylor, S. et al. PD-1 regulates KLRG1+ group 2 innate lymphoid cells. J. Exp. Med. 214, 1663\u20131678 (2017).","journal-title":"J. Exp. Med."},{"key":"595_CR27","doi-asserted-by":"publisher","first-page":"17765","DOI":"10.1073\/pnas.0708767104","volume":"104","author":"T Pentcheva-Hoang","year":"2007","unstructured":"Pentcheva-Hoang, T., Chen, L., Pardoll, D. M. & Allison, J. P. Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability. Proc. Natl Acad. Sci. USA 104, 17765\u201317770 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"595_CR28","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","volume":"186","author":"RD Michalek","year":"2011","unstructured":"Michalek, R. D. et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186, 3299\u20133303 (2011).","journal-title":"J. Immunol."},{"key":"595_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41573-019-0032-5","volume":"18","author":"CH Patel","year":"2019","unstructured":"Patel, C. H., Leone, R. D., Horton, M. R. & Powell, J. D. Targeting metabolism to regulate immune responses in autoimmunity and cancer. Nat. Rev. Drug Discov. 18, 669\u2013688 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"595_CR30","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1084\/jem.20151448","volume":"213","author":"C Wilhelm","year":"2016","unstructured":"Wilhelm, C. et al. Critical role of fatty acid metabolism in ILC2-mediated barrier protection during malnutrition and helminth infection. J. Exp. Med. 213, 1409\u20131418 (2016).","journal-title":"J. Exp. Med."},{"key":"595_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.immuni.2020.03.003","volume":"52","author":"F Karagiannis","year":"2020","unstructured":"Karagiannis, F. et al. Lipid-droplet formation drives pathogenic group 2 innate lymphoid cells in airway inflammation. Immunity 52, 620\u2013634.e6 (2020).","journal-title":"Immunity"},{"key":"595_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17813-1","volume":"11","author":"DG Helou","year":"2020","unstructured":"Helou, D. G. et al. PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity. Nat. Commun. 11, 3998 (2020).","journal-title":"Nat. Commun."},{"key":"595_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7692","volume":"6","author":"N Patsoukis","year":"2015","unstructured":"Patsoukis, N. et al. PD-1 alters T-cell metabolic reprogramming by inhibiting and promoting lipolysis and fatty acid oxidation. Nat. Commun. 6, 6692 (2015).","journal-title":"Nat. Commun."},{"key":"595_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nri3430","volume":"13","author":"N Kamada","year":"2013","unstructured":"Kamada, N., Seo, S.-U., Chen, G. Y. & N\u00fa\u00f1ez, G. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13, 321\u2013335 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"595_CR35","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3389\/fimmu.2019.01235","volume":"10","author":"T Wang","year":"2019","unstructured":"Wang, T. et al. Probiotics Lactobacillus reuteri abrogates immune checkpoint blockade-associated colitis by inhibiting group 3 innate lymphoid cells. Front. Immunol. 10, 1235 (2019).","journal-title":"Front. Immunol."},{"key":"595_CR36","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cell.2014.08.006","volume":"158","author":"NW Palm","year":"2014","unstructured":"Palm, N. W. et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158, 1000\u20131010 (2014).","journal-title":"Cell"},{"key":"595_CR37","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/gutjnl-2014-307311","volume":"64","author":"M-Y Song","year":"2015","unstructured":"Song, M.-Y. et al. Protective effects of Fc-fused PD-L1 on two different animal models of colitis. Gut 64, 260\u2013271 (2015).","journal-title":"Gut"},{"key":"595_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri2891","volume":"11","author":"M Saleh","year":"2011","unstructured":"Saleh, M. & Trinchieri, G. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat. Rev. Immunol. 11, 9\u201320 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"595_CR39","first-page":"534","volume":"118","author":"K Sugimoto","year":"2008","unstructured":"Sugimoto, K. et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118, 534\u2013544 (2008).","journal-title":"J. Clin. Invest."},{"key":"595_CR40","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ni.2002","volume":"12","author":"S Sawa","year":"2011","unstructured":"Sawa, S. et al. ROR\u03b3t+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat. Immunol. 12, 320\u2013326 (2011).","journal-title":"Nat. Immunol."},{"key":"595_CR41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature25437","volume":"554","author":"K Mao","year":"2018","unstructured":"Mao, K. et al. Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism. Nature 554, 255\u2013259 (2018).","journal-title":"Nature"},{"key":"595_CR42","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1128\/IAI.69.4.2277-2285.2001","volume":"69","author":"HC Rath","year":"2001","unstructured":"Rath, H. C. et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect. Immun. 69, 2277\u20132285 (2001).","journal-title":"Infect. Immun."},{"key":"595_CR43","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1128\/IAI.01104-10","volume":"79","author":"M Wlodarska","year":"2011","unstructured":"Wlodarska, M. et al. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect. Immun. 79, 1536\u20131545 (2011).","journal-title":"Infect. Immun."},{"key":"595_CR44","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1084\/jem.20180549","volume":"216","author":"B Di Luccia","year":"2019","unstructured":"Di Luccia, B., Gilfillan, S., Cella, M., Colonna, M. & Huang, S. C.-C. ILC3s integrate glycolysis and mitochondrial production of reactive oxygen species to fulfill activation demands. J. Exp. Med. 216, 2231\u20132241 (2019).","journal-title":"J. Exp. Med."},{"key":"595_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature13564","volume":"514","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514, 237\u2013241 (2014).","journal-title":"Nature"},{"key":"595_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.immuni.2013.10.021","volume":"40","author":"X Guo","year":"2014","unstructured":"Guo, X. et al. Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity 40, 25\u201339 (2014).","journal-title":"Immunity"},{"key":"595_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan, V. et al. Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients. Science 359, 97\u2013103 (2018).","journal-title":"Science"},{"key":"595_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy, B. et al. Gut microbiome influences efficacy of PD-1\u2013based immunotherapy against epithelial tumors. Science 359, 91\u201397 (2018).","journal-title":"Science"},{"key":"595_CR49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.24294\/ti.v1.i1.20","volume":"1","author":"JA Seidel","year":"2017","unstructured":"Seidel, J. A., Otsuka, A. & Kabashima, K. Treating tumors with immune checkpoint inhibitors: rationale and limitations. Trends Immunother. 1, 2\u20139 (2017).","journal-title":"Trends Immunother."},{"key":"595_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/ni.3318","volume":"17","author":"C Zhong","year":"2016","unstructured":"Zhong, C. et al. Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment. Nat. Immunol. 17, 169\u2013178 (2016).","journal-title":"Nat. Immunol."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00595-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00595-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00595-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T09:07:51Z","timestamp":1669367271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00595-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["595"],"URL":"https:\/\/doi.org\/10.1038\/s42255-022-00595-9","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,4]]},"assertion":[{"value":"7 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}